CHIARAVALLOTI, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 28.586
AS - Asia 5.601
EU - Europa 3.885
SA - Sud America 639
Continente sconosciuto - Info sul continente non disponibili 586
AF - Africa 85
OC - Oceania 12
Totale 39.394
Nazione #
US - Stati Uniti d'America 28.330
SG - Singapore 3.384
IT - Italia 1.009
CN - Cina 703
DE - Germania 625
RU - Federazione Russa 604
BR - Brasile 523
VN - Vietnam 434
HK - Hong Kong 417
IE - Irlanda 319
GB - Regno Unito 275
FR - Francia 256
UA - Ucraina 247
BD - Bangladesh 178
SE - Svezia 156
JP - Giappone 141
CA - Canada 139
FI - Finlandia 103
IN - India 59
KR - Corea 58
NL - Olanda 56
PL - Polonia 54
AT - Austria 45
ID - Indonesia 44
AR - Argentina 41
MX - Messico 35
ZA - Sudafrica 35
ES - Italia 33
IQ - Iraq 22
EC - Ecuador 21
TR - Turchia 20
CO - Colombia 19
CZ - Repubblica Ceca 19
UZ - Uzbekistan 19
JM - Giamaica 16
CR - Costa Rica 13
PH - Filippine 13
PK - Pakistan 13
SA - Arabia Saudita 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
LT - Lituania 10
MA - Marocco 10
MY - Malesia 10
CH - Svizzera 9
EU - Europa 9
JO - Giordania 9
AL - Albania 8
AU - Australia 8
BE - Belgio 8
KE - Kenya 8
NO - Norvegia 8
PY - Paraguay 8
BB - Barbados 7
CL - Cile 7
DK - Danimarca 7
ET - Etiopia 7
IR - Iran 7
KG - Kirghizistan 7
NP - Nepal 7
RO - Romania 7
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
GR - Grecia 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
EG - Egitto 5
GP - Guadalupe 5
HN - Honduras 5
IL - Israele 5
PR - Porto Rico 5
PT - Portogallo 5
BO - Bolivia 4
GE - Georgia 4
NZ - Nuova Zelanda 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BS - Bahamas 3
GT - Guatemala 3
HR - Croazia 3
KH - Cambogia 3
PA - Panama 3
SV - El Salvador 3
TH - Thailandia 3
TN - Tunisia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
PS - Palestinian Territory 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AW - Aruba 1
BM - Bermuda 1
Totale 38.806
Città #
Wilmington 7.325
Houston 5.769
Woodbridge 5.593
Ashburn 1.080
Singapore 1.074
Fairfield 745
San Jose 677
Chandler 612
Ann Arbor 439
Hong Kong 414
Rome 349
Seattle 342
Beijing 320
Dublin 300
New York 297
Council Bluffs 284
Cambridge 229
Medford 214
Jacksonville 212
Santa Clara 191
Dearborn 185
Los Angeles 172
The Dalles 162
Moscow 136
Ho Chi Minh City 135
Tokyo 129
Boardman 102
Hanoi 102
Lawrence 99
Lauterbourg 97
Dallas 91
Buffalo 89
São Paulo 75
Munich 58
Denver 55
North Bergen 55
Milan 53
Phoenix 52
San Diego 51
Chicago 47
Atlanta 42
Menlo Park 42
Montreal 38
Nuremberg 37
Helsinki 34
Warsaw 34
London 33
Orem 33
Toronto 33
Redondo Beach 32
San Francisco 32
Jakarta 29
Washington 29
Naples 26
Redwood City 24
Stockholm 24
Creede 23
Elk Grove Village 23
Brooklyn 22
Johannesburg 21
Vienna 21
Kunming 19
Salt Lake City 19
Chennai 18
Manchester 18
Tashkent 18
Belo Horizonte 17
Kraków 17
Nanjing 17
Norwalk 17
Poplar 17
Bologna 16
Frankfurt am Main 16
Guangzhou 16
Palo Alto 16
Columbus 15
Amsterdam 14
Brno 14
Da Nang 14
Rio de Janeiro 14
Biên Hòa 13
Haiphong 13
Monte Vista 13
Turin 13
Detroit 12
Florence 12
Mülheim 12
Carrboro 11
Lappeenranta 11
Mexico City 11
Baghdad 10
Bari 10
Boston 10
Dong Ket 10
Hải Dương 10
Kingston 10
Miami 10
Paris 10
Quito 10
Shanghai 10
Totale 29.576
Nome #
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 607
Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia 530
Studio del metabolismo cerebrale in corso di stimolo olfattivo nella Sindrome da Sensibilità Chimica Multipla: dalla (dis)percezione olfattoria al correlato neurobiologico 519
18F FDOPA uptake in brain metastasis of breast cancer 515
111In-pentetreotide SPECT/CT in pulmonary carcinoid 514
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 507
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 504
18F-choline PET/CT pitfalls in image interpretation: An update on 300 examined patients with prostate cancer 494
Comparison of 18F FDOPA PET, DSC-MRI and spectroscopy in a patient with brain metastatic lesions from lung cancer 485
A case of intracranial meningioma detected by 18F-choline PET/CT and examined by PET/MRI fusion imaging 483
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 481
18F-FDG PET/MR in herpes simplex virus encephalitis: A case study 466
Factors affecting intrapatient liver and mediastinal blood pool 18F-FDG standardized uptake value changes during ABVD chemotherapy in Hodgkin's lymphoma 464
Involvement of Subcortical Brain Structures During Olfactory Stimulation in Multiple Chemical Sensitivity 459
WIDEN: A tool for medical image management in multicenter clinical trials 459
Cortical activity during olfactory stimulation in multiple chemical sensitivity: a 18F-FDG PET/CT study 458
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 457
Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early 18F-FCH PET/CT? 457
Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP) 448
Factors affecting 18F FDOPA standardized uptake value in patients with primary brain tumors after treatment 446
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT 445
Decoupled association between 18F-FDG and 18F-FDOPA uptake in a carcinoid of the thymus 441
Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin's lymphoma? 439
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 437
Cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis. 436
Reply to comments by Laffon et al.: Liver SUV versus stage in Hodgkin's lymphoma: the total amount of uptake may play a role in the inverse relationship 430
Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection. 427
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 422
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 420
Functional correlates of t-Tau, p-Tau and Aβ1-42 amyloid cerebrospinal fluid levels in Alzheimer's disease: A 18F-FDG PET/CT study 409
PET Probe-guided surgery in patients with breast cancer: Proposal for a methodological approach 406
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 402
Cortical Involvement in Unilateral Vestibular Deficit: Early Metabolic Changes 398
Brain metabolic changes in hodgkin disease patients following diagnosis and during the disease course: An 18F-FDG PET/CT study 398
Cortical 18F FDG-PET changes during olfactory stimulation in normal subjects 397
When cognitive decline and depression coexist in the elderly: CSF biomarkers analysis can differentiate Alzheimer's disease from late-life depression 397
Cortical metabolic changes in vestibular neurutis detected by 18F-FDG PET/CT 391
Reverse perfusion pattern in myocardial spect with 99mTc-sestaMIBI. 387
Low-dose CT and contrast-medium CT in hybrid PET/CT systems for oncologic patients 382
PICASO: a personalised integrated care platform 380
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 378
Cortical metabolic arrangement during olfactory processing: Proposal for a 18F FDG PET/CT methodological approach 378
cerebellar metabolic involvement and its correlations with clinical parameters in vestibular neuritis: “tor vergata” university experience 373
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma 372
Does123I-MIBG scintigraphy really assist the diagnosis of Parkinson's disease? 363
Il coinvolgimento corticale nel deficit vestibolare acuto 362
Initial staging of hodgkin's disease: Role of contrast-enhanced 18F FDG PET/CT 358
Early and phasic cortical metabolic changes in vesibular neuritis onset 357
New acquisition of cerbral metabolic neural pathways related to olfactory stimulation 356
18F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease 356
Molecular imaging in pediatric brain tumors 352
Metabolic and electrophysiological changes associated to clinical improvement in two severely traumatized subjects treated with EMDR-A pilot study 349
Early cortical responses during vestibular neuritis 345
Cortical metabolic changes in vestibular neuritis detected by 18F-FDG PET/CT 345
18F-DOPA PET/CT and MRI findings in a patient with multiple meningiomas 344
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 341
Aspects of cerebral plasticity related to clinical features in acute vestibular neuritis: A “starting point” review from neuroimaging studies|La plasticità cerebrale correlata alle caratteristiche cliniche nella neuronite vestibolare acuta: Una revisione della letteratura di neuroimaging 340
Dopaminergic involvement in a drummer with focal dystonia: A case study 338
Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: A F-18 FDG PET/CT study 333
Cortico-subcortical metabolic correlates of olfactory processing in healthy reasting subjects 332
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 330
Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma 328
PET/CT with 18F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients: 18F–choline PET/CT bio-distribution and pitfalls. A southern Italian experience 328
A patient with a benign and a malignant primary pulmonary meningioma: An evaluation with 18F fluorodeoxyglucose positron emission tomography/computed tomography and computed tomography with iodinated contrast 326
Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study 321
Correction to: Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid (Annals of Nuclear Medicine, (2018), 32, 1, (7-15), 10.1007/s12149-017-1213-0) 314
A rare case of primary uterine non-hodgkins's lymphoma with involvement of right ovary: Staging with 18F FDG PET/CT and iodinated contrast CT 313
Early cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss 309
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 306
Ageing effect on 18 F-DOPA and 123 I-MIBG uptake: A cross-sectional study 305
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 303
Coupled Imaging with [ 18 F]FBB and [ 18 F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain 286
Evaluation of the usefulness of FDG-PET/CT for nodal staging of breast cancer 281
18F-dopa pet/ct physiological distribution and pitfalls: Experience in 215 patients 277
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients? 276
Impact of awake breast cancer surgery on postoperative lymphocyte responses 272
Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine 248
Cerebral metabolic changes related to clinical parameters in idiopathic anosmic patients during olfactory stimulation: a pilot investigation 247
PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection? 247
Comparison between Early-Onset and Late-Onset Alzheimer's Disease Patients with Amnestic Presentation: CSF and 18F-FDG PET Study 246
The role of epsilon phenotype in brain glucose consumption in Alzheimer’s disease 246
Rearfoot Transcutaneous Oximetry is a Useful Tool to Highlight Ischemia of the Heel 234
Thalamic 123I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 226
Evaluation of Task-Related Brain Activity: Is There a Role for 18F FDG-PET Imaging? 220
Theragnostic aspects and radioimmunotherapy in pediatric tumors 218
Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study 217
Medical imaging in the diagnosis of schistosomiasis: a review 213
Radiotheranostic Agents Targeting Neuroblastoma: State-of-the-Art and Emerging Perspectives 212
Subependymal spread of glioblastoma multiforme in positron emission tomography/computed tomography 212
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 205
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 204
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 199
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial 189
Long-term follow-up of endovascular treatment of renal artery aneurysms with covered stent deployment 163
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 155
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency 152
18f-fdopa pet/ct suv-derived indices and volumetric parameters correlation in patients with primary brain tumors 149
10-Year clinical experience with 18F-choline PET/CT: an Italian multicenter retrospective assessment of 3343 patients 144
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 141
[18F] FBB cortical uptake is not related to the age of onset of Alzheimer’s disease 133
Totale 34.764
Categoria #
all - tutte 109.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022781 0 0 0 69 19 74 37 65 61 74 71 311
2022/20231.543 157 139 104 151 110 293 132 178 131 36 69 43
2023/2024827 68 23 51 20 82 233 21 30 13 30 22 234
2024/20254.701 99 626 262 213 222 228 238 181 377 237 1.118 900
2025/20265.818 578 243 603 500 565 192 759 717 548 549 332 232
2026/20272.563 378 385 1.038 762 0 0 0 0 0 0 0 0
Totale 39.394